Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTP Angel Fund is an early-stage investment group launched in 2023. It focuses on companies primarily located in the Research Triangle Park region and broader Southeast US. The fund typically invests $50k–$250k per deal, with an average of $150k. Its sector focus is broad and driven by member expertise and interest rather than being limited to healthcare or biotech. Some portfolio companies are healthcare-related, but many are not.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTP Angel Fund.